Abstract
The global anti-infective market is currently valued at US$66.5 billion with
antibacterial agents accounting for over 50% of sales. The antibacterial
market is set to grow to over US$45.0 billion by 2012, driven by the uptake of
newer antibacterial agents such as glycopeptides and carbapenems which
demonstrate resistance to methicillin-resistant Staphylococcus aureus (MRSA)
and vancomycin-resistant Enterococcus (VRE) as well as other emerging strains.
Pharmaceutical companies continue to develop a new generation of antibacterial
agents such as cephalosporins, macrolides and quinolones to overcome the major
issue of drug resistance. In addition, a number of new drug classes such as
dihydrofolate reductase inhibitors (DHFR) are under evaluation which are
effective in multi drug resistant organisms.
This report examines each of the antibacterial classes in turn, assessing the
market potential and application in hospital and community-acquired infections.
The following product classes are analyzed in this report:
- aminoglycosides
- carbapenems
- cephalosporins
- dihydrofolate reductase inhibitors
- glycopeptides
- ketolides
- lipopeptides
- macrolides
- penicillins
- oxazolidinones
- pleuromutulins
- quinolones
The report assesses the overall antibacterial market, key classes and the
drivers and resistors influencing their prescription. The report provides an
overview of key products in each category, summarizing their clinical efficacy
and marketing position. The overview of the current market is given in terms
of segmentation and by leading players and their products and analyzes market
trends.
The report also examines promising pipeline products and their potential
impact on the prescription of current and new antibacterial agents and the
future of the antibacterial market.
Key Features of this report:
- Overview of the antibacterial market, including the main infectious
agents, therapeutic drug classes and key players.
- In-depth analysis of different classes of antibacterial agents, including
leading antibacterial agents and a summary of leading brands within each class.
- Comprehensive facts and figures for the antibacterial market, including
main players and drug class break-downs.
- Future trends in the antibacterial marketplace, driven by drug resistance
and patient demographics.
- Outlook for the antibacterial market, including the emergence of novel
therapies and the impact of generics.
| 
View Cart
